Phosphoproteomics analyses have identified the CDK7/POLR2A axis as a new molecular node in patient-derived epithelial ovarian cancer (EOC), and it was shown that using the CDK7 inhibitor TZH1 suppressed the proliferation of EOC [270]. This evidence concerns the gene CDK7 and ovarian carcinoma.